Effect of Intermittent Systemic Corticosteroid on Bone Metabolism in Bronchial Asthma Patients

References

• Goldstein M F, Fallon J J, Jr, Harning R. Chronic glucocoriticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116: 1733–1749
   PubMed Web of Science ®Google Scholar
• Japanese society of Allergology. Asthma Prevention and Management Guidelines. Tokyo 2006
   Google Scholar
• Adinoff A D, Hollister J R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309: 265–268
   PubMed Web of Science ®Google Scholar
• Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y. The Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005; 23: 105–109
   PubMed Web of Science ®Google Scholar
• Siminoski K, Jiang G, Adachi J D, Hanley D A, Cline G, Ioannidis G, Hodsman A, Josse R G, Kendler D, Olszynski W P, Ste Marie L G, Eastell R. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int. 2005; 4: 403–410
   Google Scholar
• Koh L K, Sedrine W B, Torralba T P, Kung A, Fujiwara S, Chan S P, Huang Q R, Rajatanavin R, Tsai K S, Park H M, Reginster JY; Osteoporosis Self-Assessment Tool for Asians (OSTA) Research Group. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporosis Int 2001; 12: 699–705
   PubMed Web of Science ®Google Scholar
• Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M. Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society. Guidelines for the use of biochemical markers of bone turnover in osteoporosis. J Bone Miner Metab 2005; 23: 97–104
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Nakatsuka K, Saitou S, Nishizawa K, Uchiyama M, Miura M. Serum cross-linked N-telopeptide of type I collagen (NTX) and serum amino-terminal propeptide of type I procollagen (PINP) in residents of a rural community in Japan: Age and sex-related values and reference limits. Osteoporosis Jpn 2002; 10: 539–544
   Google Scholar
• Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H; Osteoporosis Diagnostic Criteria Review Committee. Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001; 19: 331–337
   PubMed Web of Science ®Google Scholar
• Dahl R. Systemic side effects of inhaled corticosteroids inpatients with asthma. Respir Med 2006; 100: 1307–1317
   PubMed Web of Science ®Google Scholar
• Halpern M T, Schmier J K, Van Kerkhove M D, Watkins M, Kalberg C J. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of meta-analysis. Ann Allergy Asthma Immunol 2004; 92: 201–207
   PubMed Web of Science ®Google Scholar
• Chang D J, Ji C, Kim K K, Casinghino S, McCarthy T L, Centrella M. Reduction in transforming growth factor beta receptor 1 expression and transcription factor CBFa 1 on bone cells by glucocorticoid. J Biol Chem 1998; 273: 4892–4896
   PubMed Web of Science ®Google Scholar
• Gohel A, McCarthy M B, Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 1999; 140: 5339–5347
   PubMed Web of Science ®Google Scholar
• Weinstein R S, Jilka R L, Parfitt A M, Manolagas S C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 1998; 102: 274–282
   PubMed Web of Science ®Google Scholar
• Weinstein R S, Chen J, Powers C C, Stewart S A, Landes R D, Bellido T, Jilka R L, Parfitt A M, Manolagas S C. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 2002; 109: 1041–1048
   PubMed Web of Science ®Google Scholar
• Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y, Barnes P J, Miyatake A. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 2001; 16: 782–787
   PubMed Web of Science ®Google Scholar
• Saag K G, Shane E, Boonen S, Marín F, Donley D W, Taylor K A, Dalsky G P, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 2007; 357: 2028–2039
   PubMed Web of Science ®Google Scholar
• Van Staa T P, Leufkens H G, Cooper C. The epidemiology of corticosteroid-induced osteoporosis; a meta-analysis. Osteoporosis Int 2002; 13: 777–787
   PubMed Web of Science ®Google Scholar
• Gourlay M, Franceschini N, Sheyn Y. Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol; 2007; 26: 144–153
   PubMed Web of Science ®Google Scholar
• Godschalk M, Downs R W. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 1988; 3: 113–115
   PubMed Web of Science ®Google Scholar
• Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, Milanio E, Bertold A, Angeli A. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab 2004; 89: 4923–4928
   PubMed Web of Science ®Google Scholar